Investments Summarized Financial Information (Details) - USD ($) $ in Thousands	3 Months Ended						9 Months Ended
	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Sep. 30, 2020	Jun. 30, 2020	Sep. 30, 2019		Jun. 30, 2019
Schedule of Equity Method Investments [Line Items]
Gross loss	$ 11,246			$ 11,240			$ 32,497		$ 32,517
Loss from operations	(6,835)			(6,784)			(19,504)		(27,968)
Net loss attributable to NantOmics	(11,000)	$ (48,289)		(16,377)	$ (14,713)	$ (19,923)	(36,224)		(51,013)	[1]
Net loss	$ (11,042)		$ 23,065	$ (16,377)			$ (36,266)		$ (51,013)
NantOmics
Schedule of Equity Method Investments [Line Items]
Revenues					847			$ 349			$ 3,913
Gross loss					(1,239)			(1,641)			(2,573)
Loss from operations					(4,436)			(7,806)			(17,541)
Impairment on equity investments					0			0			(12,265)
Net loss attributable to NantOmics					(3,296)			(2,559)			(26,005)
Net loss					$ (3,333)			$ (2,618)			$ (26,263)

[1] The statements for the nine months ended September 30, 2020 and 2019 include the Connected Care Business (see Note 4).